Behçet's syndrome

Current Rheumatology Reports

Volumn 12, Issue 6, 2010, Pages 429-435

  Yazici, Yusuf ^b   Yurdakul, Sebahattin ^a   Yazici, Hasan ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b NONE

Author keywords

Azathioprine; Beh et's syndrome; Eye disease; Prognosis; Vasculitis

Indexed keywords

ADALIMUMAB; ALPHA2A INTERFERON; AZATHIOPRINE; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETANERCEPT; INFLIXIMAB; METHYLPREDNISOLONE ACETATE; PLACEBO; SALAZOSULFAPYRIDINE; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ACNE; ALOPECIA; ANEURYSM; ARTERY; ARTHRALGIA; ARTHRITIS; BEHCET DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CEREBRAL SINUS THROMBOSIS; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DEPRESSION; ENTHESITIS; ERYTHEMA NODOSUM; FEVER; FLU LIKE SYNDROME; GASTROINTESTINAL DISEASE; GENITAL ULCER; HUMAN; INJECTION SITE REACTION; LEUKOPENIA; MOUTH ULCER; NEUROLOGICAL COMPLICATION; PAPULE; POLYNEUROPATHY; PRACTICE GUIDELINE; PULMONARY ARTERY ANEURYSM; PUSTULE; RETINA VASCULITIS; REVIEW; SIDE EFFECT; SOMNOLENCE; SYSTEMIC VASCULITIS; TERATOGENESIS; UVEITIS; VASCULAR DISEASE; VEIN; VEIN THROMBOSIS;

BEHCET SYNDROME; FEMALE; HUMANS; MALE;

EID: 77958111462     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-010-0132-z     Document Type: Review

References (49)

1. H Behçet 1937 Uber rezidivierende, aphthose, dürch ein Virus verursachte Geshwure am Munde, am Auge und an den Genitalien [in German] Dematologische Wochenschrift 36 1152 1157
2. Yurdakul S, Hamuryudan V, Fresko I, et al.: Behçet's syndrome. In Rheumatology, edn 4. Edited by Hochberg MC, Silman AJ, Smolen YS, et al. Philadelphia, PA: Mosby Elsevier; 2008:1561-1565.
3. DH Verity JE Marr S Ohno, et al. 1999 Behçet's disease, the Silk Road and HLA-B51: historical and geographical perspectives Tissue Antigens 54 213 220 1:STN:280:DyaK1Mvks1yntA%3D%3D 10.1034/j.1399-0039.1999.540301.x 10519357 (Pubitemid 29443840)
4. O Demirhindi H Yazici P Binyildiz, et al. 1981 Silivri Fener koyu ve yoresinde Behçet hastaligi sikligi ve bu hastaligin toplum icinde taranabilmesinde kullanabilecek bir yontem [in Turkish] Cerrahpasa Tip Fak Derg 12 509 514
5. S Yurdakul I Gunaydin Y Tuzun, et al. 1988 The prevalence of Behçet's syndrome in a rural area in northern Turkey J Rheumatol 15 820 822 1:STN:280:DyaL1M%2FhtFOgsA%3D%3D 3172095
6. S Ozen Y Karaaslan O Ozdemir, et al. 1998 Prevalence of juvenile chronic arthritis and familial Mediterranean fever in Turkey: a field study J Rheumatol 25 2445 2449 1:STN:280:DyaK1M%2FnsVWmtg%3D%3D 9858443
7. L Jaber G Milo GJ Halpern, et al. 2002 Prevalence of Behçet's disease in an Arab community in Israel Ann Rheum Dis 61 365 366 1:STN:280:DC%2BD387psFehtg%3D%3D 10.1136/ard.61.4.365 11874845 (Pubitemid 34257752)
8. NG Papoutsis MB Abdel-Naser A Altenburg, et al. 2006 Prevalence of Adamantiades-Behçet's disease in Germany and the municipality of Berlin: results of a nationwide survey Clin Exp Rheumatol 24 5 Suppl 42 S125 1:STN:280:DC%2BD28nktFartw%3D%3D 17067445
9. T Shimizu GE Ehrlich G Inaba, et al. 1979 Behçet disease (Behçet syndrome) Semin Arthritis Rheum 8 223 260 1:STN:280: DyaE1M3kvVylsA%3D%3D 10.1016/0049-0172(79)90004-0 382361 (Pubitemid 9200080)
10. H Yazici MA Chamberlain Y Tuzun, et al. 1984 A comparative study of the pathergy among Turkish and British patients with Behçet's disease Ann Rheum Dis 43 74 75 1:STN:280:DyaL2c7islSitg%3D%3D 10.1136/ard.43.1.74 6696522
11. H Yazici Y Tuzun H Pazarli, et al. 1984 Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behçet's syndrome Ann Rheum Dis 43 783 789 1:STN:280:DyaL2M7itFSrsg%3D%3D 10.1136/ard.43.6.783 6524980
12. C Mat N Göksugur B Engin, et al. 2006 The frequency of scarring after genital ulcers in Behçet's syndrome: a prospective study Int J Dermatol 45 554 556 10.1111/j.1365-4632.2006.02859.x 16700790
13. T Ergun O Gurbuz G Dogusoy, et al. 1998 Histopathologic features of the spontaneous pustular lesions of Behçet's syndrome Int J Dermatol 37 194 196 1:STN:280:DyaK1c3hsFeqsQ%3D%3D 10.1046/j.1365-4362.1998.00276.x 9556106 (Pubitemid 28140744)
14. Y Tüzün H Yazici H Pazarli, et al. 1979 The usefulness of the nonspecific skin hyperreactivity (the pathergy test) in Behçet's disease in Turkey Acta Derm Venereol 59 77 79 84476
15. Mat C, Demirkesen C, Melikoglu M, et al.: Behçet's syndrome. In Handbook of Systemic Autoimmune Diseases. The Skin in Autoimmune Diseases. Edited by Sarzi-Puttini P, Doria A, Girolomini G, Kuhn A. Philadelphia, PA: Elsevier; 2006:185-206.
16. I Tugal-Tutkun S Onal R Altan-Yaycioglu, et al. 2004 Uveitis in Behçet disease: an analysis of 880 patients Am J Ophthalmol 138 373 380 10.1016/j.ajo.2004.03.022 15364218 (Pubitemid 39208563)
17. S Yurdakul H Yazici Y Tuzun, et al. 1983 The arthritis of Behçet's disease: a prospective study Ann Rheum Dis 42 505 515 1:STN:280: DyaL2c%2Fit1OgtA%3D%3D 10.1136/ard.42.5.505 6625699
18. E Diri C Mat V Hamuryudan, et al. 2001 Papulopustular skin lesions are seen more frequently in patients with Behçet's syndrome who have arthritis: a controlled and masked study Ann Rheum Dis 60 1074 1076 1:STN:280:DC%2BD3MrlsFCntw%3D%3D 10.1136/ard.60.11.1074 11602484 (Pubitemid 32989185)
19. Muftuoglu AU, Yurdakul S, Yazici H, et al.: Vascular involvement in Behçet disease: a review of 129 cases. In Recent Advances in Behcet Disease. Edited by Lehner T, Barnes CG. London: Royal Society of Medicine Services; 1986:255-260.
20. JT Lie 1992 Vascular involvement in Behçet's disease: arterial and venous and vessels of all sizes J Rheumatol 19 341 343 1:STN:280: DyaK383ltFOntA%3D%3D 1578445
21. V Hamuryudan S Yurdakul F Moral, et al. 1994 Pulmonary arterial aneurysms in Behçet's syndrome: a report of 24 cases Br J Rheumatol 33 48 51 1:STN:280:DyaK2c3hsFSisQ%3D%3D 10.1093/rheumatology/33.1.48 8162457
22. E Seyahi M Melikoglu C Akman, et al. 2007 Pulmonary vascular involvement in Behçet's syndrome (BS) [abstract] Arthritis Rheum 56 Suppl 853
23. E Seyahi S Ugurlu R Cumali, et al. 2008 Atherosclerosis in Behçet's syndrome Semin Arthritis Rheum 38 1 12 1:CAS:528: DC%2BD1cXoslGktbw%3D 10.1016/j.semarthrit.2007.09.009 18221989
24. G Akman-Demir P Serdaroglu B Tasci 1999 Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behcet Study Group Brain 122 2171 2182 10.1093/brain/122.11.2171 10545401
25. CJ Webb RJ Moots AC Swift 2008 Ear, nose and throat manifestations of Behçet's disease: a review J Laryngol Otol 122 1279 1283 1:STN:280:DC%2BD1cjms1ymug%3D%3D 10.1017/S0022215108002703 18616840
26. U Korman M Cantasdemir S Kurugoglu, et al. 2003 Enteroclysis findings of intestinal Behcet disease: a comparative study with Crohn disease Abdom Imaging 28 308 312 1:STN:280:DC%2BD3s7pvV2rug%3D%3D 10.1007/s00261-002-0036-0 12719899 (Pubitemid 36676160)
27. M Melikoglu E Kural-Seyahi K Tascilar, et al. 2008 The unique features of vasculitis in Behçet's syndrome Clin Rev Allergy Immunol 35 40 46 1:CAS:528:DC%2BD1cXhtF2hsrnP 10.1007/s12016-007-8064-8 18172779
28. A Gül M Inanç L Ocal, et al. 2000 Familial aggregation of Behçet's disease in Turkey Ann Rheum Dis 59 622 625 10.1136/ard.59.8.622 10913059 (Pubitemid 30617087)
29. A Gül 2005 Behçet's disease as an autoinflammatory disorder Curr Drug Targets Inflamm Allergy 4 81 83 10.2174/1568010053622894 15720240 (Pubitemid 40584857)
30. H Yazici I Fresko 2005 Behçet's disease and other autoinflammatory conditions: what's in a name? Clin Exp Rheumatol 23 4 Suppl 38 S1 S2 16273757
31. R Tunc S Saip A Siva, et al. 2004 Cerebral venous thrombosis is associated with major vessel disease in Behçet's syndrome Ann Rheum Dis 63 1693 1694 1:STN:280:DC%2BD2crntl2rsQ%3D%3D 10.1136/ard.2003.018515 15547099 (Pubitemid 39573708)
32. G Hatemi H Bahar S Uysal, et al. 2004 The pustular skin lesions in Behcet's syndrome are not sterile Ann Rheum Dis 63 1450 1452 1:STN:280:DC%2BD2crgvFKmuw%3D%3D 10.1136/ard.2003.017467 15479894 (Pubitemid 39433950)
33. I Fresko S Ugurlu F Ozbakir, et al. 2005 Anti-Saccharomyces cerevisiae antibodies (ASCA) in Behçet's syndrome Clin Exp Rheumatol 23 4 Suppl 38 S67 S70 1:STN:280:DC%2BD2MrpsV2muw%3D%3D 16273768
34. AU Muftuoglu H Yazici S Yurdakul, et al. 1986 Behçet's disease. Relation of serum C-reactive protein and erythrocyte sedimentation rates to disease activity Int J Dermatol 25 235 239 1:STN:280:DyaL283it1ykug%3D%3D 10.1111/j.1365-4362.1986.tb02232.x 3710672
35. Criteria for diagnosis of Behçet's disease 1990 International Study Group for Behçet's Disease Lancet 335 1078 1080
36. TW O'Neill AS Rigby AJ Silman, et al. 1994 Validation of the International Study Group criteria for Behcet's disease Br J Rheumatol 33 115 117 10.1093/rheumatology/33.2.115 8162473
37. H Yazici E Seyahi S Yurdakul 2008 Behçet's syndrome is not so rare: why do we need to know? Arthritis Rheum 58 3640 3643 10.1002/art.24146 19035470
38. E Kural-Seyahi I Fresko N Seyahi, et al. 2003 The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center Medicine (Baltimore) 82 60 76 10.1097/00005792-200301000-00006 (Pubitemid 36139801)
39. E Aktulga M Altac A Muftuoglu, et al. 1980 A double blind study of colchicine in Behçet's disease Haematologica 65 399 402 1:STN:280:DyaL3M%2Fpt1Sjtg%3D%3D 6778795
40. S Yurdakul C Mat Y Tuzun, et al. 2001 A double-blind trial of colchicine in Behçet's syndrome Arthritis Rheum 44 2686 2692 1:CAS:528: DC%2BD38XpvVY%3D 10.1002/1529-0131(200111)44:11<2686::AID-ART448>3.0.CO;2- H 11710724 (Pubitemid 33049346)
41. H Yazici H Pazarli CG Barnes, et al. 1990 A controlled trial of azathioprine in Behçet's syndrome N Engl J Med 322 281 285 1:STN:280:DyaK3c7hsVegtQ%3D%3D 10.1056/NEJM199002013220501 2404204
42. V Hamuryudan Y Ozyazgan N Hizli, et al. 1997 Azathioprine in Behçet's syndrome: effects on long-term prognosis Arthritis Rheum 40 769 774 1:CAS:528:DyaK2sXivVehtrs%3D 10.1002/art.1780400425 9125262 (Pubitemid 27157585)
43. K Masuda A Nakajima A Urayama, et al. 1989 Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease Lancet 333 1093 1096 10.1016/S0140-6736(89)92381-7
44. V Hamuryudan C Mat S Saip, et al. 1998 Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial Ann Intern Med 128 443 450 1:CAS:528:DyaK1cXitFeltLg%3D 9499327
45. E Alpsoy C Durusoy E Yilmaz, et al. 2002 Interferon alfa-2a in the treatment of Behçet disease: a randomized placebo-controlled and double-blind study Arch Dermatol 138 467 471 1:CAS:528:DC%2BD38XjtlCjsb8%3D 10.1001/archderm.138.4.467 11939808
46. J Gueudry B Wechsler C Terrada, et al. 2008 Long-term efficacy and safety of low-dose interferon alpha2a therapy in severe uveitis associated with Behçet disease Am J Ophthalmol 146 837.e1 844.e1 10.1016/j.ajo.2008.08. 038
47. PP Sfikakis N Markomichelakis E Alpsoy, et al. 2007 Anti-TNF therapy in the management of Behcet's disease-review and basis for recommendations Rheumatology (Oxford) 46 736 741 1:CAS:528:DC%2BD2sXntlOjtL0%3D 10.1093/rheumatology/kem034 (Pubitemid 47061701)
48. M Melikoglu I Fresko C Mat, et al. 2005 Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study J Rheumatol 32 98 105 1:CAS:528:DC%2BD2MXht1yqsb0%3D 15630733
49. • Hatemi G, Silman A, Bang D, et al.: EULAR recommendations for the management of Behçet's disease: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2008, 67:1656-1662. This is a very good review of the current information on treatment of BS.